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L e t t e r s t o t h e e d i t o r
Obsessive-compulsive disorder and cingulotomy
To The ediTor: We read with interest the article by Sheth et al. 5 (Sheth SA, Neal J, Tangherlini F, et al: Lim bic system surgery for treatmentrefractory obsessivecom pulsive disorder: a prospective longterm followup of 64 patients. Clinical article. J Neurosurg 118:491-497, March 2013). The authors published their results with anterior cin gulotomy (cingulomotomy) for obsessivecompulsive dis order (OCD) with a longterm followup. Their results have been very good and comparable to those of other major studies. In this context, we would like to share the work done by Prof. V. Balasubramaniam at the Madras Insti tute of Neurology in Chennai, India. [1] [2] [3] [4] Stereotactic cingu lotomy has been performed at the institute since 1972 for OCD and other disorders, including drug addiction. In the preMRI era, angiography and ventriculography were used. The target in the cingulum was localized to the area be tween pericallosal and callosomarginal arteries. The Ma dras Institute of Neurology has the largest series of cases of drug addiction treated with stereotactic cingulotomy.
response: We thank the authors for their thoughtful comments regarding our paper. Functional neurosurgery continues to provide novel therapeutic options for patients with otherwise intractable medical and psychiatric condi tions. As always, the enthusiasm for these procedures must be tempered with a cautious and ethical approach to pa tient selection and treatment.
Petroclival tumors
To The ediTor: With great interest, we read the recent article by Gupta and Salunke 1 (Gupta SK, Salunke P: Intra dural anterior petrosectomy for petroclival meningiomas: a new surgical technique and results in 5 patients. Tech nical note. J Neurosurg 117:1007-1012, December 2012), in which they presented a variation of the seminal ante rior petrosectomy by Kawase et al. 2, 3 Gupta and Salunke 1 described 5 patients affected by petroclival meningiomas who underwent an intradural anterior petrosectomy tai lored according to tumor extension. They claimed signifi cantly minimized bone removal, which was addressed in their anatomical study. As they correctly pointed out, the main limitation of all supratentorial approaches occurs when tumors extend far inferiorly to the internal auditory meatus. 1 Even though technical variations for petroclival meningiomas were introduced in their work, we have been performing intradural anterior petrosectomy for chordo mas and chondrosarcomas combined with an extended pterional approach. 7 With the coming of age of skull base surgery, the initial trend toward extensive bone resection-which has contributed enormously to improvements in surgical ex posure, tumor resectability, and patient outcome-has been replaced by less invasive approaches as experience has increased. In 1983 Samii et al. 4, 5 introduced the ret rosigmoid intradural suprameatal approach (RISA) for large petroclival meningiomas with invasion of the mid dle fossa. This approach is based on suprameatal tubercle drilling and eventual division of the tentorium, bringing the carotid arteries, oculomotor nerves, posterior clinoid, posterior cerebral arteries, and even the optic nerves into surgical view. 5 When compared with large petrous bone exposures, the RISA makes for very straightforward ac cess, is not timeconsuming or technically demanding, and reduces the risk of hearing loss, facial palsy, and CSF leakage. Seoane and Rhoton 6 provided a detailed descrip tion of the RISA surgical anatomy.
Apart from the controversy behind the best surgical approach to the petroclival area, we believe that the ap proach should be tailored to the type of tumor extension. 5 It is worth mentioning that for most petroclival meningio mas, the surgical corridor is created by the surgeon when performing supratentorial approaches, whereas access is provided by the tumor during posterior fossa approaches. As a matter of fact, the amount of bone drilling in the report by Gupta and Salunke 1 corresponds exactly to the suprameatal bone, which is also safely resected through a RISA. Note, however, that while suprameatal bone drill ing is crucial for tumor removal during supratentorial approaches, it is supplementary for posterior fossa ap proaches.
As experience with RISA has been gained, we have noted that small petroclival tumors are completely blocked by the suprameatal bone and the petrosal vein. In such cases, bone drilling is essential for tumor resection. Con versely, for large tumors, the role of suprameatal drilling has been overestimated. Since the tumor provides the sur gical corridor, most of the surgery is performed above the cerebellum, and the middle fossa is reached after tento rium division. Thus, we hypothesize that the term "RISA" indicates a simplification of the surgical procedure. In this regard, surgical access would be better defined as a retrosi gmoid intradural supracerebellar suprameatal transtento rial approach (RISSTA). The term "RISSTA" seems more appropriate by illustrating a complete overview of the ex tension of the surgical approach. The RISSTA particularly profits from the semisitting position because of the fall of the cerebellum and facilitated CSF and blood drainage, what we have called the "Tübingen concept."
Gupta and Salunke 1 are to be congratulated for their minimally invasive approach and good surgical results, which demonstrate the recent trend in the literature to ward easier, faster, and safer exposures. Over time, we realized that suprameatal bone drilling is part of the sur gical procedure as required, but it should not be acknowl edged as a sine qua non condition for complete tumor removal given that incomplete resection is frequently as sociated with tumor invasiveness and not with inadequate exposure. response: I appreciate the comments by Tatagiba et al. and tend to agree with most of their observations. In my clinical practice, practically all of the petroclival tu mors are surgically treated with either of the 2 following approaches: 1) a frontotemporoorbitozygomatic cranioto my followed by a transsylvian transtentorial approach 2 or 2) a retrosigmoid approach. With the first technique, the long axis of the tentorial edge is the line of approach. The technique is used for tumors that have a large supratento rial extension and are primarily anterior and superior to the internal acoustic meatus. There may be an additional need for an intradural anterior petrosectomy in some pa tients-and this decision is made intraoperatively-and the extent of bone drilling is need based. We have ob served that the amount of bone that must be drilled is often only a few millimeters, and its removal allows tu mor behind the petrous apex to be delivered into the op erative field and removed under direct visualization, as we described in our article. We use the second approach, which is excellent, in most patients with petroclival and cerebellopontine angle tumors when the lesion extends inferior and/or posterior to the internal acoustic meatus. The philosophy in selecting one of these approaches is based on the desire to avoid transgressing the course of intracranial nerves. I have also described a variation of the retrosigmoid approach, which I like to call the "ex tended retrosigmoid approach." 1 In it the standard retro sigmoid craniotomy is used and augmented by either a tentorial incision or drilling of the suprameatal portion of the petrous bone. It is helpful in tumors with a supraten torial extension of the tumor along the medial side of the temporal lobe or tumor extension anterior to the petrous apex (Fig. 1) . It is similar to the technique described by Tatagiba et al. In neurosurgical procedures for tumors, the need for rapid and accurate diagnosis is indeed great, and frozen sections do not always provide essential information. Cur rently, we are also investigating the value of cellcycle analysis for rapid intraoperative characterization of brain tumors. We have modified a previously published proto col, reported by our group, 1,2 and we are able to provide, within 6 minutes, an accurate and reproducible charac terization of a brain tumor. Briefly, immediately after tu mor excision, samples of the tumor are minced using a Medimachine System for 1 minute in phosphatebuffered saline buffer (Ca 2+ and Mg 2+ free, with 0.5 mg/ml RNase), and a cell suspension is obtained. The suspension is then filtered and cells are counted using an automated hematol ogy analyzer to a final concentration of 1.0 × 10 6 cells/ ml. Cells are then processed immediately for staining by adding propidium iodide (125 μg/ml) and after 3-minute flow cytometric analysis is performed. All the stained samples are analyzed using a FACSCalibur flow cytom eter, equipped with 2 lasers (488 nm and 635 nm) and 6 parameters (FSC, SSC, and FL1-FL4) and using Cell Quest software. Chicken red blood cells and normal cells obtained from the peripheral blood mononuclear cells are used as the standard to define the position of the diploid G 0 /G 1 peak in the DNA histograms. These cells can be mixed with the sample in a second tube before staining and then used as a reference to determine the degree of DNA content aberration.
Our brain tumor material consists of surgically re moved tissue from 63 patients undergoing surgery for brain tumors, mainly gliomas and meningiomas. Of those, 39 lesions were analyzed using the standard method and 24 lesions were evaluated using the fast cellcycle analysis protocol (submitted data). After performing analyses using both methods, we found that the results were equal. The frozensection diagnosis was done independently from the flow analysis, and the results were reported without knowl edge of the flow cytometry data. The permanent section diagnosis was considered the gold standard. In our study protocol, different from that of Shioyama et al., we have evaluated the G 0 /G 1 , Sphase, G 2 /M phase fraction and ploidy status. In gliomas (18 high grade and 6 low grade), a cutoff value of 78% of G 0 /G 1 fraction and 4.3% of Sphase fraction could accurately differentiate lowgrade from high-grade gliomas (82.2% sensitivity and 100% specific ity vs 94.1% sensitivity and 100% specificity, respectively) ( Fig. 1) . Furthermore, glioblastomas (14 of 18 highgrade tumors) with a G 0 /G 1 value of ≤ 69% and an Sphase frac tion more than 6% had significantly lower survival. Similar findings were demonstrated in meningiomas (19 benign, 5 atypical, and 2 anaplastic). Benign meningiomas could be accurately differentiated from anaplastic tumors based on G 0 /G 1 , Sphase, and G 2 /M phase fraction levels ( Fig.  1 ). Metastatic tumors (9 cases) exhibited low G 0 /G 1 phase fraction, high Sphase and G 2 /M phase fraction levels, and nearly all tumors were aneuploid.
In conclusion, cell-cycle analysis by flow cytometry, as also reported by Shioyama et al., 3 has several advan tages over microscopic investigation of pathological ma terial on frozen tissue sections. Apart from the identifica tion of tumor margins, this technique has the potential to offer an accurate and rapid characterization of the malignancy of a brain mass and possibly provide a rapid assessment of a patient's overall prognosis. In this letter, our findings support those of Shioyama et al. and provide evidence that, methodologically, fast cellcycle analysis by flow cytometry gives reproducible results among labo ratories worldwide, and it can be further improved, with an even shorter time to establishing a correct diagnosis. response: We thank Dr. Vartholomatos and colleagues for their interest in our work. It is good to know that their data also confirm the usefulness of intraoperative flow cytometry for brain tumor characterization. However, the protocol for tissue analysis that they presented is different from ours. It seems that our method includes fewer steps due to simultaneous cell isolation and staining. Moreover, with our technique, just 1-2 mm 3 of tissue is required for investigation, whereas a larger amount may be needed if mincing with the Medimachine System is performed. In fact, the volume of the specimen required for effective flow cytometry analysis constitutes a rather important point for the intraoperative application of the technique. First, the smaller the sample is, the lower is the risk of possible di agnostic errors caused by averaging of the DNA content of cells obtained from different areas of the histopathologi cally heterogeneous glioma. 2 Second, the limited required volume of the specimen permits one to perform very pre cise sampling under the guidance of intraoperative neu ronavigation, even from the affected or adjacent eloquent brain structures. 4 Analysis of the flow cytometry data according to our protocol and to the method presented by Vartholomatos and colleagues also differs. Calculation of the original MI applied in our study considers composite evaluation of the number of cells in S and G 2 /M phases, aneuploid cells, and cells containing more DNA than G 2 /M phase It seems that the optimal protocol for investigation should be determined by the desired objectives. Our ex perience demonstrates that intraoperative flow cytometry may provide valuable diagnostic information, and its use in addition to evaluation of frozen tissue sections may be rather helpful. Because of its speed, the technique may significantly facilitate histopathological monitoring of the resected tissue. Since, in our current practice, surgery for cerebral glioma is always directed at the maximum possible resection of the neoplasm (while preserving functionally important cerebral structures), 4 we consider precise determination of the lesion border to be very im portant and represents the main reason for the application of intraoperative flow cytometry. Certainly this method may be also helpful for detailed characterization of the tumor's malignant potential 3 and prediction of patient prognosis, 1 but, in our opinion, such goals do not require fast data analysis and use of the technique during the sur gical procedure itself. 1 However, their statement that 5-ALA "confirmed that there was subependymal and ependymal spread" is unsupported, as they do not provide separate biopsies of those infiltrated areas. Optic radiation spreading would provide an alternative explanation for the connection of the recurrent tumor to the original site and would also explain the clinical symptoms.
In a number of papers, intense fluorescence from 5ALA has been shown to be highly predictive of tumor his tol ogy; [3] [4] [5] [6] however, faint fluorescence in the ependy mal wall might be an exception. We reviewed 45 patients with tu mors contacting the ventricular wall and found ep endymal fluorescence in 28. Selective biopsies were per formed when taking the sample was considered safe, and the results were negative in 3 of 8 cases. 7 Furthermore, clinical evo lution of the group of patients with ependymal fluorescence was similar to the group without it, suggest ing that there was not true ependymal spreading. Clinica Universidad de Navarra Navarra, Spain
Disclosure
The authors report no conflict of interest. 2 It is, however, difficult to justify making the leap from functional imaging to deep brain stimulation (DBS) or a focused lesioning. Although MRgFUS with the ExAblate System (InSightec) necessitates hair removal and fixation of the head, it permits noninvasive temporary lesioning of discrete areas of the brain by heating the tissue to a lower temperature than would be used in creating a permanent lesion. Temporary lesioning of different areas of the brain in the same session may help determine the optimal target within a circuit. While DBS is not equivalent to lesioning, 1 temporary lesioning may help elucidate the pathways in volved in certain disabling conditions, such as pain or tin nitus, and help predict a patient's ability to tolerate lesioning or DBS in those regions. response: We appreciate the comments of Dr. Schwalb, and we agree that transcranial MRgFUS has significant potential for the diagnostic exploration of deep functional neurosurgical targets in addition to its obvious nearterm use in incisionless, deep brain, stereotactic le sioning. We have explored the thermal thresholds that can be utilized during thalamotomy procedures to confirm/ test the targeted region. It is our hope that future studies will harness the nonthermal effects of acoustic energy by mechanical perturbation of neurons. Already in the labo ratory, research has demonstrated the ability to activate or inhibit neuronal circuits in vivo using lower or pulsed in tensities that do not result in heating. [1] [2] [3] [4] [5] [6] We share Dr. Schwalb's enthusiasm for the potential of this technology to noninvasively "map" the brain. This technique could, like Wada testing, be used diagnosti cally to test neuronal circuits immediately before discrete stereotactic lesioning or to identify new therapeutic cir cuits and diseases for functional neurosurgical treatment. In the early 1950s, Lars Leksell conceived of the Gam ma Knife as a noninvasive approach to perform func tion al neurosurgery. What should not be forgotten is that he orig inally invented focused ultrasound for this purpose and later abandoned it after treating a number of patients be cause, at that time, there was no way to focus ultrasound through the intact skull and a craniotomy was required. Furthermore, there was no imaging technology to guide and control the treatment.
Recently, there has been a resurgence of interest in focused ultrasound as a technology for noninvasive le sioning in the brain. With contemporary computer tech nology, multiple beams of ultrasound energy can be ac curately and precisely focused deep within the cranium. Furthermore, MRI provides realtime guidance and con trol.
Focused ultrasound for essential tremor was initiated by W. Jeffrey Elias and colleagues at the University of Virginia. Dr. Elias conducted a pilot study of feasibil ity, safety, and preliminary efficacy in 15 patients, all of whom have been followed up closely for over 1 year 2 Both studies utilized the protocol developed at the University of Virginia; they were conducted under the auspices of the Focused Ultrasound Foundation Movement Disorder Steering Committee and were funded by the Focused Ul trasound Foundation. Based on the encouraging results of these two studies, an international, multicenter pivotal study for safety and efficacy employing a randomized, doubleblind, shamcontrolled design will begin enroll ing patients in the latter part of 2013.
If the pivotal trial confirms the results of the two pi lot studies, MRguided focused ultrasound surgery will become a viable noninvasive option for treating essential tremor and perhaps a variety of other intracranial disor ders. The advantages of this noninvasive approach are that it does not use radiation, the results are immediate and verifiable, and thermal neuromodulation can be used to confirm the location of the target. response: The editorial that accompanied our re cent article on Gamma Knife thalamotomy for tremor was written by Dr. Jeffrey Elias, one of Dr. Kassell's col leagues. Dr. Elias noted the recent research on the use of focused ultrasound as a lesion generator. Dr. Kassell points to the recent report in Lancet Neurology that de scribes 4 patients, one of whom developed a sensory defi cit from the thalamic lesion, and another who developed a deep venous thrombosis, thought to be related to the length of the procedure. That research will continue. This study provides useful information in the discus sion of one of the most controversial topics in cerebral AVM management, which is, should patients with an un ruptured AVM be observed or should they undergo treat ment to eliminate the malformation and reduce the risk of future intracranial hemorrhages. 19 As mentioned by the authors, a randomized trial of unruptured brain arteriove nous malformations (ARUBA) was funded by the Nation al Institute of Neurological Disorders (U01 NS051483) and began enrolling patients in April 2007. This trial is designed to compare the risks of observation versus those of prophylactic intervention for patients diagnosed with unruptured intracranial AVM. Exclusion criteria for the ARUBA trial, in addition to prior bleeding, include age less than 18 years, prior AVM treatment, presence of mul tiple AVMs, and a modified Rankin Score (mRS) ≥ 2. The primary end points of the ARUBA trial are the combined risk of death or stroke and risk of clinical impairment, defined as an mRS ≥ 2. The ARUBA trial has been criti cized for a number of reasons, including the intended fol lowup period after randomization (planned, 5-10 years), which is considered insufficient for a disorder that is com monly diagnosed in patients with life expectancies of 30 years or more. 2, 11 Ding and colleagues from the University of Virginia report the outcomes of singlefraction SRS in a large co hort of patients (n = 444) with unruptured AVM (median clinical followup, 74 months). 4 The mean AVM volume was 4.2 cm 3 ; the median margin dose was 20 Gy. Of note, 122 patients (27.4%) underwent preSRS embolization and 20 patients (4.5%) had prior microsurgery. Overall, the au thors reported a cumulative AVM obliteration rate of 62% after one or more SRS procedures. Clinical deterioration was noted in 30 patients (6.8%). The most frequent cause of neurologic decline was postSRS bleeding. The authors concluded that SRS provided a reasonable benefit-to-risk ratio and recommended treatment for younger patients, patients with largervolume AVMs, and patients with a higher radiosurgerybased AVM score (RBAS). 13 We re cently published the outcomes of 174 patients with unrup tured AVM having SRS at our center from 1990 to 2005 using the same eligibility criteria and outcome measures as the ARUBA trial (median followup, 64 months). 16 In our series, the obliteration rate after one or more proce dures was 79%. Overall, the risk of hemorrhagic stroke or death was 10% at 5 years and 12% at 10 years. The risk of patients' having clinical impairment (mRS ≥ 2) was 8% at 5 years and 12% at 10 years. Larger AVM volume was associated with an increased risk of stroke resulting in death or clinical impairment after SRS. The 10year risk of mRS ≥ 2 for patients with an RBAS ≤ 1.50 was 2% in comparison with 18% for patients with an RBAS > 1.50. Thus, like Ding et al., we found that SRS was a safe and effective option for patients with unruptured intracranial AVM, especially if they were younger, with many years of risk for AVM hemorrhage.
I was surprised to see the authors refer to the "Pitts burgh radiosurgerybased AVM score" throughout this paper. In contrast to the SpetzlerMartin grading system, which was designed to predict outcomes after AVM re section, 18 the RBAS was developed by the Mayo Clinic in collaboration with the University of Pittsburgh over a period of 15 years as a method to specifically predict out comes after AVM SRS. 13, 14 Since its publication in 2002, 5 years after I left the University of Pittsburgh and joined the Department of Neurological Surgery at the Mayo Clinic, the original and modified versions of the RBAS have been cited more than 175 times. This grading scale has been shown to be valid after not only Gamma Knife SRS, 1 but also after LINACbased and CyberKnife pro cedures. 3, 17 To the best of my knowledge, only one publi cation erroneously referred to Pittsburgh as the origin of this grading scale in its abstract. 20 In fact, the University of Pittsburgh group did not use this misnomer in its re cent sixpart opus on AVM radiosurgery published last year in the Journal of Neurosurgery, [5] [6] [7] [8] [9] [10] and Dr. Luns ford himself, in a commentary on an article by Pollock et al., has referred to it as "the Mayo Clinic's proposed AVM grading system." 15 Proper citation of appropriate references lies at the heart of intellectual exchange, as it allows scholars to give credit to other scholars for their hard work and their ideas. Also, proper citation provides a guide for readers who are interested in learning more about a topic. The history of the development and testing of the RBAS has recently been published. response: We thank Dr. Pollock for his letter regard ing our article. We agree that there is a favorable benefittorisk ratio for radiosurgery in selected cohorts of patients with unruptured AVM. In particular, those patients who are younger and whose AVMs exhibit features indicating a greater likelihood of rupture over time are likely to benefit from radiosurgery.
Regarding the name of the radiosurgery scale cited in our paper, we utilized the name noted in the recent peer reviewed journal article published by Dr. Pollock and col leagues in which it was referred to as the Pittsburgh mod ified radiosurgery-based AVM grading scale. 5 The mod ified radiosurgery-based AVM system (RBAS) was de rived from 220 AVM patients treated with radiosurgery at the University of Pittsburgh from 1987 to 1992 and sub sequently tested in a cohort of 247 patients treated at the Mayo Clinic from 1990 to 2001. 1 The system has been re vised over the years, and it was the modified radiosurgerybased arteriovenous malformation grading scale outlined in the publication by Wegner et al. (2011) that we utilized in our study. 2, 3, 5 The modified scale has been validated by a number of centers, and we have also done so in our current study. We have recently developed a new AVM grading system that we believe will prove simpler to use, as it does not involve an algebraic equation, but this new system ap pears no less reliable. 4 The Radiosurgery AVM scale was derived from a series of 1012 AVM patients.
Boot camp
To The ediTor: Selden et al. 2 should be congratu lated for their evaluation of the neurological surgeons' boot camp courses ( First of all, although there was improvement in knowledge, there was no report of improvement in per formance among learners at the boot camp. There was no audit of their work, no results of multisource feedback on their behavior, and no direct assessment of their pro cedural skills by a senior trainee. Doctors are notoriously unreliable at reporting on their own knowledge and skills; only by means of objective methods will we come closer to knowing their actual ability. Perhaps if a followup study is planned, some of these outcomes might be mea sured.
Secondly, the boot camps were a multifaceted inter vention, and so it is difficult to say which facet of the boot camp led to the positive outcomes. Perhaps a study in which different groups of students received different in terventions would be worthwhile.
Thirdly and lastly, like many medical education in terventions, the cost of the boot camps was not evaluated. Even if we assume that the boot camps were effective, it is impossible to say whether or not they were costeffective. According to Liam Donaldson "in the current, costcon strained environment, those funding the education of our doctors will no longer tolerate an approach of quality at any cost." 1 Increasingly the providers of medical educa tion will have to thoroughly cost out their interventions and prove that those interventions are not just effective but costeffective also. response: My coauthors and I thank Dr. Walsh for his thoughtful comments. Furthermore, we agree fully with his expressed priorities for further development of edu cational science related to the neurosurgical boot camp courses. As mentioned in our discussion, the principal current activity of the course curriculum committee is to introduce validated assessments of course handson skills. Dr. Walsh is also correct that we did not control for or independently vary which of the multifaceted course interventions may have contributed to the markedly pos itive educational outcomes. As previously described, 2 these courses were introduced in 2010 after all US neu rosurgical residencies incorporated the postgraduate Year 1 in order to replace introductory curricular mate rial previously provided by general surgery training pro grams. Like the vast majority of medicine and surgery we practice, very little medical and surgical education is validated in any way. Although additional validation is a laudable goal, which we continue to pursue, we do not feel that it should stand in the way of efficiently introducing carefully designed and purposed curricular material to fill obvious gaps in training. Furthermore, the face validity of trainees creating their first bur holes in a beef scapula rather than the cranium of a living patient, for example, is almost inescapable.
A cooperative group of educators working under the supervision of the neurosurgical program directors' or ganization, the Society of Neurological Surgeons, designed and implemented the boot camp courses. The courses were piloted and refined before national adoption.
1 They con tinue to undergo iterative curriculum improvement based on trainee and faculty input. 1 The unique aspect of the neu rosurgical boot camp effort is its introduction of a uniform preparatory curriculum for all Accreditation Council for Graduate Medical Education (ACGME)-accredited train ing programs in a major specialty. All available outcome parameters to date support the value of these courses and provide direction for the further important investigation of their educational effectiveness and costeffectiveness.
